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Abstract—Over the last two decades, a significant body of
research has established a link between cannabis use and
psychotic outcomes. In this study, we aim to propose a novel
symbiotic machine learning and statistical approach to pattern
detection and to developing predictive models for the onset of
first-episode psychosis. The data used has been gathered from
real cases in cooperation with a medical research institution,
and comprises a wide set of variables including demographic,
drug-related, as well as several variables specifically related
to the cannabis use. Our approach is built upon several
machine learning techniques whose predictive models have
been optimised in a computationally intensive framework.
The ability of these models to predict first-episode psychosis
has been extensively tested through large scale Monte Carlo
simulations. Our results show that Boosted Classification Trees
outperform other models in this context, and have significant
predictive ability despite a large number of missing values in
the data. Furthermore, we extended our approach by further
investigating how different patterns of cannabis use relate to
new cases of psychosis, via association analysis and bayesian
techniques.
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I. INTRODUCTION
A number of US states have already legalised or are in
the process of legalising the use of cannabis. Some other
countries such as Uruguay had previously done so. More-
over, currently cannabis is one of the most used illicit drugs
in the world. However, research established a significant
link between cannabis use and psychotic symptoms, and that
cannabis use is the most preventable risk factor for psychosis
[1]. In this context, any harm caused by the cannabis use, in
particular in connection to psychosis, should be quantified.
As such, more recently, researchers sought to understand
whether specific patterns of cannabis use (such as potency
[2] or age [3]) relate to higher risk of psychotic disorders.
One study estimated that nearly a quarter of all new psy-
chosis patients in South London (UK) could be attributed
to the use of high-potency, skunk-like cannabis [4]. The
same study estimated that the risk of experiencing psychotic
disorders is roughly three times higher for those who are
daily users of cannabis, compared to those who are not users.
However, there is still scope for further understanding of
the links between patterns of cannabis use and psychosis [5].
Most studies so far are limited by incomplete or inconsistent
records, or a lack of detailed variables, but also by the
methodologies used, which are mainly based on a number
of conventional statistical techniques such as hypotheses
formulation and verification via statistical tests, logistic
regression modelling, etc. These methods are traditionally
well recognised and used in medical research, but in many
situations they do not match the large potential of the modern
machine learning methods.
The field of machine learning has advanced at tremendous
pace in recent years, with advanced predictive techniques
being developed and improved upon. In order for these
technologies to become truly refined, they must be applied
for use in a variety of fields and subsequently challenged to
find relevant solutions [6]. One such area of application is the
field of medical research, which has a wide range of potential
uses for machine learning [7]–[9]. Several recent studies
have sought to compare a variety of algorithms in predicting
patient survival after surgeries such as breast cancer surgery
[10]. These studies suggest that machine learning can pro-
vide medical research with powerful techniques beyond the
traditional statistical approaches mostly used in this area. In
biomedical engineering, several recent papers explored the
potential for classification algorithms to detect disease. This
has led to the publication of additional guidance for medical
researchers on how to interpret and question such findings
[11]. Last but not least, there is a tremendous interest in cur-
rent interdisciplinary research into exploiting the power of
machine and statistical learning to enable further progress in
the new and promising area of Precision Medicine, in which
predictive modelling plays a key role in forecasting treatment
outcomes, and thus decisively contributes in optimising and
personalising treatments for patients [9], [12].
In this study, we propose a novel symbiotic machine
learning and statistical approach to pattern detection and to
developing predictive models for the onset of first-episode
psychosis. The dataset we based our study upon was col-
lected in previously conducted medical studies as described
in [4], and comprises a wide set of variables including
demographic, drug-related, as well as several other variables
with specific information on the participants’ history of
cannabis use. Prior to the prediction modelling, a significant
effort in our work was involved in the data pre-processing
due to inherent challenges present in data collected in a case-
control study involving many missing values, multiple en-
codings of related information, a significantly large number
of variables, etc.
The prediction modelling phase consisted of investigat-
ing several machine learning techniques such as k-Nearest
Neighbours, Support Vector Machine with different kernels,
Decision Trees, Bagged Trees, Boosted Classification Trees,
eXtreme Gradient Boosting and Random Forests, whose
predictive models have been optimised in a computationally
intensive framework. The ability of these models to predict
first-episode psychosis, which is a novelty and one of the
contributions of this paper, has been extensively verified
through large scale Monte Carlo simulations in the same
computationally intensive framework.
Then, the predictive value of cannabis related variables
with respect to first-episode psychosis was demonstrated in
this work by showing that there is a statistically signifi-
cant difference between the performance of the predictive
models built with and without cannabis variables. We were
inspired in this approach, proposed and implemented here,
by the Granger causality techniques [13], which are used to
demonstrate that some variables have predictive information
on other variables in a regression context, as opposed to
classification, which is mainly the case in our framework.
Finally, we extended our approach by further investigating
how different patterns of cannabis use relate to new cases of
psychosis, via association analysis and bayesian techniques
such as Apriori and Bayesian Networks, respectively.
The rest of the paper is organized as follows. Section 2
presents our approach to predicting the first-episode psy-
chosis, based on experimenting with various machine learn-
ing algorithms and on computational intensive model opti-
misations. The section includes also the data pre-processing,
and investigates the outcomes of the extensive Monte Carlo
simulations in order to study the variation of the model
performances that may have been affected also by the pres-
ence of a high proportion of missing values in the data. In
Section 3, we build optimised prediction models without the
cannabis attributes to study if there is a statistically signifi-
cant difference between the predictive power obtained with
and without the cannabis attributes. Then, we investigate and
discuss further relationships between the cannabis variables
and the first-episode psychosis. Finally, the directions for
future work and the conclusion are presented in Section 4.
II. PREDICTING FIRST-EPISODE PSYCHOSIS: A
COMPUTATIONALLY INTENSIVE APPROACH
The data used to develop our novel approach to predicting
the first-episode psychosis is a part of a case-control study
at the inpatient units of the South London and Maudsley
NHS Foundation Trust [4]. The clinical data consists of
1106 records, including 489 patients, 370 controls and 247
unlabeled records. Those described as patients were patients
of the Trust who at one time presented with first-episode
psychosis; controls were recruited from the same local area
by a dedicated research team. Each record refers to a par-
ticipant of the study and has 255 possible attributes, which
were divided into four categories. The first category consists
of demographic attributes which represent general features
such as gender, race, and level of education. Secondly, drug-
related attributes contain information on the use of non-
cannabis drugs such as tobacco, stimulants and alcohol. The
third category is formed of genetic attributes which were
removed from the analysis for the purpose of this study.
The final category contains cannabis-related attributes such
as the duration of use, frequency, cannabis type, etc.
In order to build our approach to predicting the first-
episode psychosis, the data required a set of pre-processing
transformations, including feature selection, data sampling,
data type conversions as needed by training certain types of
models, and missing value imputation.
The prediction modelling consisted of considering various
machine learning techniques which are suitable for this
classification problem and the dataset, including k-Nearest
Neighbours, Support Vector Machine with different ker-
nels, Decision Trees, Bagged Trees, Boosted Classification
Trees, eXtreme Gradient Boosting and Random Forests [6],
[14]. The models were evaluated based on accuracy, area
under curve, precision, sensitivity, specificity, and Cohen’s
kappa statistic. All experiments, including model training
and optimisation based on repeated cross validations, and
extended Monte Carlo simulations based on split validations
to investigate the stability of the performances of the models,
were conducted in a computationally intensive framework,
using the packages R, Rapidminer, Weka and Apache Spark,
by performing a parallel processing on a Data Science
cluster of 11 servers based on Xeon processors and 832GB
of RAM.
A. Data Pre-Processing
Data pre-processing was performed before modelling in
order to rationalise the complexity of the data and prepare
the data for use. The pre-processing consisted of the stages
of rationalisation and refinement.
1) Rationalisation: The work of this stage sought to per-
form a high-level simplification of the dataset, and included
several steps. First, records that were missing critical data
Table I
CANNABIS USAGE ATTRIBUTES
Attribute Description
lifetime cannabis user Ever used cannabis: yes or no
age first cannabis Age when first used cannabis: 7 to 50
age first cannabis under15 Age less than 15 when first used
cannabis: yes, no or never used
age first cannabis under14 Age less than 14 when first used
cannabis: yes, no or never used
current cannabis user Current cannabis user: yes or no
cannabis fqcy Pattern of cannabis use: never used,
only at weekends, or daily
cannabis measure Cannabis usage measure: none, hash less
than once per week, or hash at weekends,
hash daily, skunk less than once per week,
or skunk at weekends, skunk daily
cannabis type Cannabis type: never used, hash, or skunk
duration Cannabis use duration: 0 to 41 (months)
were removed from the dataset. This included records with
missing labels, as well as records for which all cannabis-
related variables were missing. Secondly, certain variables
were removed from the data. This primarily involved vari-
ables that were deemed to be irrelevant to the study (such as
those related to individual IDs of the study participants), and
also included variables which were outside the scope of the
current study (for example, certain gene-related variables).
In addition, any numeric predictors that had zero or near-
zero variance were dropped. Lastly, we sought to make the
encoding of missing values consistent across the data set.
2) Refinement: This stage requires several steps: first,
the variables were re-labelled to provide more intuitive
descriptions of the data contained within. Then, since in
multiple situations some variables had a similar meaning as
other variables, yet there were often missing values for some
records in some of these variables, a process of imputation
was used to effectively combine the information from related
variables into one. Finally, any attribute that contained more
than 50% missing values was dropped from the study.
We then removed any record for which more than 70%
of the remaining attributes contained missing values. The
resulting dataset, after the transformations above, contained
777 records and 29 attributes. The records are divided into:
446 patients and 331 controls. A summary of some of these
fields - specifically the ones that relate to cannabis use such
as type, age first use, and duration - can be seen in Table I.
B. Missing Values and Imputation
Although the dataset was pre-processed and attributes
with more than 50% missing values have been removed
from the dataset, it still contains a large number of missing
values. Of the 777 records, only 22.5% are complete records.
This volume of missing information makes modelling more
challenging, but often is the reality of medical and social
research. In this study, we used a superset of the variables
that were explored in [4], in order to examine the efficacy
of machine learning to deal with a significant number of
Figure 1. Summary of the ratio of missing values for each attribute
missing values present on the whole collected dataset. A plot
of the proportion of missing values is shown in Figure 1.
Only two variables - the output attribute patient and the input
attribute lifetime cannabis user - are populated completely.
On the other extreme, the attribute children is missing values
in 48% of the records.
Missing values can exist in medical data sets for many
reasons such as some participant may be unable to fully
complete a survey, or may want to abstain from answering
certain questions, or do not attend follow-up appointments,
etc. Alternatively, researchers may decide to add or remove
certain attributes from the data collection process over time.
Missing values mostly need to be imputed before applying
pattern discovery techniques. However, the predictive power
of the data may depend significantly on the way missing
values are treated. While some machine learning algorithms,
such as decision trees [6], have the capability to handle
missing data outright, most machine learning algorithms do
not. Usually, in medical research applications missing values
are imputed using a supervised learning technique such as k-
Nearest Neighbour. These imputation techniques do not have
theoretical formulations but have been much implemented in
practice [15].
In this work, we opt for the tree bagging imputation
from the caret package [14] to impute the missing values
in the training data sets which are generated in the cross
validations, or in the repeated experiments of the Monte
Carlo simulations. This imputation process is thus repetitive,
becomes a part of each model training and is therefore
evaluated as part of each model’s performance metrics. We
should note also those imputations performed with k-Nearest
Neighbour led finally to slightly weaker predictive results
than those based on tree bagging imputations, although
the latter are more computationally costly as based on an
ensemble technique. This of course matters in a computa-
tionally intensive framework comprising an intensive model
Table II
SUMMARY OF PARAMETERS TUNED FOR EACH MODEL
Model Optimised Parameter(s)
C5 Decision Tree Iter = 70 , Model = rules
Winnow = False
Boosted Trees Iter = 100, MaxDepth= 5, Nu = 0.1
eXtreme Gradient Boosting Nrounds = 50, MaxDepth = 3
Eta= 0.3 , Gamma= 0 ,
Colsample= 0.8, MinChild =1
Bagged CART None
Random Forests Mtry = 30
SVM (Linear) Cost = 16
SVM(Radial) Cost = 16384 , Gamma = 3.05e-05
SVM (Poly) Cost = 64, Degree = 1, Scale= 0.1
KNN K = 5
optimisation and extensive Monte Carlo simulations. As
such the use of adequate computing power is the solution
we benefited of to handle also this aspect.
As a final transformation of the data, since some predic-
tion modelling algorithms, such as Support Vector Machines,
work only with numeric data, we transformed the input
nominal variables into dummy variables, obtaining a dataset
of 91 variables.
C. Training and Optimising Predictive Models
For the purpose of developing optimised predictive mod-
els for the first-episode psychosis, the values of the param-
eters for each of the algorithms have been controlled by
suitably chosen grids. Predictive models have been fitted, in
a 10-cross validation procedure, on each training set after
tree bagging imputations of missing values on the same
training set, and have been tested on each test set. The
best performance models with their parameters have been
selected for subsequent comparison. For instance, Support
Vector Machine algorithm has been tuned for different
kernels and values for the cost and gamma parameters. The
best model was obtained on the Radial (RBF) kernel, with
the cost 16384, and gamma 3.052e−05.
A summary of the models with the chosen optimised pa-
rameters is shown in Table II. The key performance measure
was the accuracy (the rate of accurate classification) and
we monitored also Kohen’s kappa statistic (the agreement
between actual values and predictions, adjusted for what
could be expected from pure chance). Values of initial
estimates of accuracy and kappa for all models can be seen
in Table III.
Based on these results, the models that were selected
for further analysis were Boosted Classification Trees (Ad-
aBoost), Random Forests and Support Vector Machine with
a Radial kernel.
D. Monte Carlo Simulations
Due to expected potential variations of the predictive mod-
els’ performance, depending on the datasets for training and
testing, but in particular due to the uncertainties introduced
Table III
INITIAL ESTIMATION OF MODEL ACCURACY & KAPPA
Model Accuracy Kappa
SVM (Radial) 0.7824 0.5519
AdaBoost 0.7850 0.5586
Random Forests 0.7798 0.5465
xgbTree 0.7786 0.5432
C5 Decision Tree 0.7682 0.5211
Bagged CART 0.7540 0.4950
SVM (Linear) 0.7619 0.5078
SVM (Poly) 0.7657 0.5160
KNN 0.6923 0.5074
by the missing values in the data, we conducted extensive
Monte Carlo simulations to study these variations, and thus
the stability of the models. In particular the simulations for
each of the three algorithms, Boosted Classification Trees,
Random Forests, and Support Vector Machine with a Radial
kernel, consisted of 10,000 stratified split validations with a
3/4 and 1/4 split for training and testing sets, respectively. On
each training set a tree bagging imputation was performed
prior to fitting a model with its corresponding optimal pa-
rameters. The models’ performances consisting of accuracy,
precision, sensitivity, specificity, area under the curve, and
kappa were estimated on the test set in each iteration. The
aggregation of all iterations formed various distributions of
the above performance measures.
Figure 2 shows histogram plots of the Monte Carlo
simulations for highest-performing models based on Boosted
Classification Trees. These models achieved a mean accu-
racy of 79.0% (95% CI [.73, .84]) and a mean kappa of .56
(95% CI [.45, .66]). The latter shows significant predictive
information of the input attributes over the first-episode
psychosis.
We remark a good predictive power and stability of these
models, based on an acceptable level of variation of their
performance measures evaluated across extensive Monte
Carlo experiments.
III. CANNABIS ATTRIBUTES’ PREDICTIVE
INFORMATION OVER FIRST-EPISODE PSYCHOSIS
After performing Monte Carlo simulations, the best per-
forming models have been further analysed in order to better
understand the predictive power of the cannabis-related
attributes over the first-episode psychosis. Moreover we
have investigated the link between cannabis-related attributes
and the first-episode psychosis via association analysis and
bayesian inference based techniques.
A. Predicting First-Episode Psychosis Without Cannabis
Attributes
We re-fit best-performing models with the three chosen
algorithms (Boosted Classification Trees, Random Forests
and Support Vector Machine with a Radial kernel) but
this time with the cannabis-related attributes, represented
Figure 2. Monte Carlo simulation for Boosted Classification Trees
in Table I, removed from the dataset. The performances
obtained with and without the cannabis-related attributes
are compared using Student’s t-test. That is, the predictive
value of cannabis-related attributes with respect to first-
episode psychosis is demonstrated by showing that there is a
statistically significant difference between the performances
of the predictive models built with and without the cannabis
variables. We were inspired in this approach we propose
here, by the Granger causality techniques [13], which are
used to demonstrate that some variables have predictive
information on other variables in a regression context (as
opposed to classification, in this case).
Our analysis shows that the accuracy of all models
decreased around 7% if the cannabis-related attributes are
removed from the process of building the predictive models.
If we compare, for instance, the accuracies of the best two
Random Forests models obtained on the data sets with and
without the cannabis attributes, the p-value obtained for the
one-tailed t-test was 0.0003. We conclude that the model
with cannabis attributes has higher predictive accuracy. In
other words, the additional cannabis variables jointly account
for predictive information over the first-episode psychosis.
B. Cannabis Use and First-Episode Psychosis Associations
To further explore the link between the cannabis attributes
and the first-episode psychosis, we look into detecting pat-
terns in data with association analysis and bayesian inference
techniques such as Apriori [16] and Bayesian Networks [17],
respectively.
A repetitive fine tuning of Apriori led to the detection of
the top 6 rules represented in Figure 3. The quality of these
rules is expressed by their confidence estimates, and by 95%
confidence intervals for these estimates. The rules represent
patterns in the general local population in the mentioned
area, since the data sample is representative of this area’s
Figure 3. Top association rules
population. The first rule states that if a participant were
a cannabis user who consumes skunk daily, then there is
an 85% likelihood that this participant is a first-episode
psychosis patient. This rule shows evidence of a strong
association between using skunk daily, and the first-episode
psychosis. If this type of cannabis is used daily or less often,
then the likelihood of the first-episode psychosis decreases
from 85% to 79%, as expressed by rules 1 and 3 together.
For a general type of cannabis which is used daily, the
likelihood of a user to be a first-episode psychosis patient
decreases from 85% to 74%, as expressed by rules 1 and 4
together. Rule number 2 supports findings from [2], [4] by
associating the age of the first use of high potency cannabis
with the psychosis onset. Rule number 5, having a 73%
confidence, is consistent with findings from [18] regarding
the onset of psychosis among cannabis users in relation
to a cannabis consumption starting at the age of 15 and
younger. Finally, rule number 6 expresses the finding that
if a participant were a cannabis user who used cannabis for
at least 6 months, then there is a 71% likelihood that this
participant is a first-episode psychosis patient.
Recently, Bayesian Networks have been used in Psy-
chiatry as a decision model for supporting the diagno-
sis of dementia, Alzheimer’s disease and mild cognitive
impairment [17]. We have applied this machine learning
technique to further detect the interaction between the first-
episode psychosis and the cannabis attributes. As such only
cannabis-related attributes were used as predictors in fitting
the Bayesian Network model, whose DAG is depicted in
Figure 4. The model details suggest that duration and
cannabis type are among the most predictive attributes. The
Bayesian Network probability distributions (not included
here due to lack of space) show that subjects who started
using cannabis by the age of 15, and consumed cannabis
daily for more than 6 months, are twice more likely to be
patients rather than controls. On the other hand, subjects
who started using cannabis by the age of 15 and consumed
cannabis only at the weekend for more than 6 months,
increase their chance by 1.5 times to be patients rather than
controls. In addition, the model confirms that subjects who
used skunk daily are twice more likely to be patients rather
than controls. These findings support the idea that cannabis
use could lead to the onset of the first-episode psychosis.
Figure 4. Bayesian Network for cannabis variables
IV. CONCLUSION AND DIRECTIONS OF FURTHER WORK
The aim of this work has been to propose a novel sym-
biotic machine learning and statistical approach to pattern
detection and to developing predictive models for the onset
of the first-episode psychosis. The predictive models we
developed in this novel approach have been optimised in a
computationally intensive framework. They exhibited a good
predictive power and stability based on an acceptable level
of variation of their performance measures evaluated across
extensive experiments encapsulated in a series of large-scale
Monte Carlo simulations.
A significant proportion of the models performance vari-
ation may be explained by the uncertainties present in
the data, represented by the high proportion of missing
values. As such it would be interesting to further investigate
how this prediction performances variation evolves with the
thresholds for missing data used in the selection of the
attributes and records
Another direction of research that will be explored next
consists of investigating the impact of including genotype
data in the study, and redefining the predictive modelling
approach by taking into account the particularities of the
newly introduced data, such as the high dimensionality.
Finally, we are currently investigating into the first-
episode psychosis predictiveness enhancements by consid-
ering Artificial Neural Network and Deep Learning ap-
proaches.
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